Migration of Splenic Lymphocytes Promotes Liver Fibrosis Through Modification of T Helper Cytokine Balance in Mice

Overview

Journal J Gastroenterol

Specialty Gastroenterology

Date 2015 Mar 1

PMID 25724556

Citations 17

Authors

Kazutaka Tanabe

Kojiro Taura

Yukinori Koyama

Gen Yamamoto

Takahiro Nishio

Yukihiro Okuda

Kojiro Nakamura

Kan Toriguchi

Kenji Takemoto

Kenya Yamanaka

Keiko Iwaisako

Satoru Seo

Masataka Asagiri

Etsuro Hatano

Shinji Uemoto

Affiliations

Soon will be listed here.

Abstract

Background: Sustained liver injury causes liver fibrosis and eventually cirrhosis. Understanding the pathophysiological mechanisms of liver fibrosis and interventions in the fibrotic process is crucial for improving the prognosis of patients with chronic liver diseases. Although studies have shown that splenectomy suppresses liver fibrosis, the mechanism by which this occurs is poorly understood. The present study focuses on the immunological functions of the spleen to investigate its role in liver fibrosis.

Methods: BALB/c and severe combined immunodeficiency (SCID) mice underwent splenectomies or sham operations prior to induction of liver fibrosis with carbon tetrachloride or thioacetamide.

Results: Sirius red staining and hydroxyproline assays showed that splenectomy suppressed liver fibrogenesis in BALB/c mice. Reverse transcription PCR analysis of T helper type 1 (Th1) and T helper type 2 (Th2) cytokines demonstrated that splenectomy shifted the Th1/Th2 balance in the liver towards Th1 dominance. In SCID mice, the inhibitory effect on liver fibrosis was abrogated. The number of CD4(+) T helper lymphocytes in the spleen decreased after liver injury. Green fluorescent protein positive (GFP(+)) splenocytes were transplanted into the spleens of syngeneic wild-type mice to trace their destination after fibrosis induction. GFP(+)CD4(+) lymphocytes appeared in the liver after induction of fibrosis, and flow cytometry revealed the vast majority of them were Th2 lymphocytes. Transfer of splenocytes via the portal vein into syngeneic splenectomized mice cancelled the suppressive effect of splenectomy on liver fibrosis.

Conclusions: The present study demonstrated that Th2-dominant splenic lymphocytes migrate into the liver and promote liver fibrosis by shifting the cytokine balance towards Th2 dominance. Splenectomy suppresses the progression of fibrosis at least partly by restoring the Th1/Th2 balance.

Citing Articles

Intravital imaging of splenic classical monocytes modifying the hepatic CX3CR1 cells motility to exacerbate liver fibrosis via spleen-liver axis.

Han C, Zhai Y, Wang Y, Peng X, Zhang X, Dai B Theranostics. 2024; 14(5):2210-2231.

PMID: 38505603 PMC: 10945343. DOI: 10.7150/thno.87791.

Broadening Horizons: Exploring mtDAMPs as a Mechanism and Potential Intervention Target in Cardiovascular Diseases.

Luan Y, Luan Y, Jiao Y, Liu H, Huang Z, Feng Q Aging Dis. 2024; 15(6):2395-2416.

PMID: 38270118 PMC: 11567272. DOI: 10.14336/AD.2023.1130.

The spleen as a possible source of serine protease inhibitors and migrating monocytes required for liver regeneration after 70% resection in mice.

Elchaninov A, Vishnyakova P, Kuznetsova M, Gantsova E, Kiseleva V, Lokhonina A Front Cell Dev Biol. 2023; 11:1241819.

PMID: 37745290 PMC: 10512715. DOI: 10.3389/fcell.2023.1241819.

The spleen tyrosine kinase (SYK): A crucial therapeutic target for diverse liver diseases.

Zhao Y, Liu R, Li M, Liu P Heliyon. 2022; 8(12):e12130.

PMID: 36568669 PMC: 9768320. DOI: 10.1016/j.heliyon.2022.e12130.

Extrahepatic factors in hepatic immune regulation.

Zhang S, Lu S, Li Z Front Immunol. 2022; 13:941721.

PMID: 36052075 PMC: 9427192. DOI: 10.3389/fimmu.2022.941721.

References

CHEEVER A, Williams M, Wynn T, Finkelman F, Seder R, Cox T . Anti-IL-4 treatment of Schistosoma mansoni-infected mice inhibits development of T cells and non-B, non-T cells expressing Th2 cytokines while decreasing egg-induced hepatic fibrosis. J Immunol. 1994; 153(2):753-9. View

Akahoshi T, Hashizume M, Tanoue K, Shimabukuro R, Gotoh N, Tomikawa M . Role of the spleen in liver fibrosis in rats may be mediated by transforming growth factor beta-1. J Gastroenterol Hepatol. 2002; 17(1):59-65. DOI: 10.1046/j.1440-1746.2002.02667.x. View

Farah I, Mola P, Kariuki T, Nyindo M, Blanton R, King C . Repeated exposure induces periportal fibrosis in Schistosoma mansoni-infected baboons: role of TGF-beta and IL-4. J Immunol. 2000; 164(10):5337-43. DOI: 10.4049/jimmunol.164.10.5337. View

Li H, Xiong S, Zhang S, Liu S, Luo Y, Zou P . Interleukin 2 production and its relationship with T lymphocyte subsets in patients with obstructive jaundice. J Tongji Med Univ. 1992; 12(3):164-8. DOI: 10.1007/BF02887818. View

Czaja M, Weiner F, Takahashi S, Giambrone M, van der Meide P, Schellekens H . Gamma-interferon treatment inhibits collagen deposition in murine schistosomiasis. Hepatology. 1989; 10(5):795-800. DOI: 10.1002/hep.1840100508. View

Murata K, Ito K, Yoneda K, Shiraki K, Sakurai H, Ito M . Splenectomy improves liver function in patients with liver cirrhosis. Hepatogastroenterology. 2008; 55(85):1407-11. View

Katz S, Ryan K, Ahmed N, Plitas G, Chaudhry U, Kingham T . Obstructive jaundice expands intrahepatic regulatory T cells, which impair liver T lymphocyte function but modulate liver cholestasis and fibrosis. J Immunol. 2011; 187(3):1150-6. PMC: 3372324. DOI: 10.4049/jimmunol.1004077. View

Baroni G, DAmbrosio L, Curto P, Casini A, Mancini R, JEZEQUEL A . Interferon gamma decreases hepatic stellate cell activation and extracellular matrix deposition in rat liver fibrosis. Hepatology. 1996; 23(5):1189-99. DOI: 10.1002/hep.510230538. View

Vierucci A, De Martino M, Novembre E, Surrenti C, Gabrielli M, Biadaioli R . [Effect of the serum of patients with cholestasis on lymphocyte E rosette formation]. Ann Sclavo. 1977; 19(5):1119-29. View

10.

Swirski F, Nahrendorf M, Etzrodt M, Wildgruber M, Cortez-Retamozo V, Panizzi P . Identification of splenic reservoir monocytes and their deployment to inflammatory sites. Science. 2009; 325(5940):612-6. PMC: 2803111. DOI: 10.1126/science.1175202. View

11.

Popov Y, Sverdlov D, Sharma A, Bhaskar K, Li S, Freitag T . Tissue transglutaminase does not affect fibrotic matrix stability or regression of liver fibrosis in mice. Gastroenterology. 2011; 140(5):1642-52. PMC: 3374132. DOI: 10.1053/j.gastro.2011.01.040. View

12.

Chaignaud B, White J, Nie C, GROGAN J . Splenocytes from bile duct ligated rats do not elicit a normal immune response in the intact host. Am Surg. 1994; 60(1):7-11. View

13.

Patsenker E, Schneider V, Ledermann M, Saegesser H, Dorn C, Hellerbrand C . Potent antifibrotic activity of mTOR inhibitors sirolimus and everolimus but not of cyclosporine A and tacrolimus in experimental liver fibrosis. J Hepatol. 2010; 55(2):388-98. DOI: 10.1016/j.jhep.2010.10.044. View

14.

Sugawara Y, Yamamoto J, Shimada K, Yamasaki S, Kosuge T, Takayama T . Splenectomy in patients with hepatocellular carcinoma and hypersplenism. J Am Coll Surg. 2000; 190(4):446-50. DOI: 10.1016/s1072-7515(99)00294-x. View

15.

Roh Y, Park S, Lim C, Kim B . Depletion of Foxp3+ Regulatory T Cells Promotes Profibrogenic Milieu of Cholestasis-Induced Liver Injury. Dig Dis Sci. 2014; 60(7):2009-18. DOI: 10.1007/s10620-014-3438-2. View

16.

Vitetta E, Brooks K, Chen Y, Isakson P, Jones S, Layton J . T-cell-derived lymphokines that induce IgM and IgG secretion in activated murine B cells. Immunol Rev. 1984; 78:137-57. DOI: 10.1111/j.1600-065x.1984.tb00480.x. View

17.

Novobrantseva T, Majeau G, Amatucci A, Kogan S, Brenner I, Casola S . Attenuated liver fibrosis in the absence of B cells. J Clin Invest. 2005; 115(11):3072-82. PMC: 1265860. DOI: 10.1172/JCI24798. View

18.

Friedman S . Mechanisms of hepatic fibrogenesis. Gastroenterology. 2008; 134(6):1655-69. PMC: 2888539. DOI: 10.1053/j.gastro.2008.03.003. View

19.

Kodama T, Takehara T, Hikita H, Shimizu S, Li W, Miyagi T . Thrombocytopenia exacerbates cholestasis-induced liver fibrosis in mice. Gastroenterology. 2010; 138(7):2487-98, 2498.e1-7. DOI: 10.1053/j.gastro.2010.02.054. View

20.

Watanabe M, Murata S, Hashimoto I, Nakano Y, Ikeda O, Aoyagi Y . Platelets contribute to the reduction of liver fibrosis in mice. J Gastroenterol Hepatol. 2008; 24(1):78-89. DOI: 10.1111/j.1440-1746.2008.05497.x. View